GR82020B - - Google Patents

Info

Publication number
GR82020B
GR82020B GR74816A GR840174816A GR82020B GR 82020 B GR82020 B GR 82020B GR 74816 A GR74816 A GR 74816A GR 840174816 A GR840174816 A GR 840174816A GR 82020 B GR82020 B GR 82020B
Authority
GR
Greece
Prior art keywords
spiro
trione
imidazolidine
indoline
pyridylmethyl
Prior art date
Application number
GR74816A
Other languages
Greek (el)
English (en)
Inventor
Alan Jeffrey Hutchison
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GR82020B publication Critical patent/GR82020B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • External Artificial Organs (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR74816A 1983-05-25 1984-05-24 GR82020B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/497,962 US4464380A (en) 1983-05-25 1983-05-25 Imidazolidinedione derivatives

Publications (1)

Publication Number Publication Date
GR82020B true GR82020B (enExample) 1984-12-12

Family

ID=23979057

Family Applications (1)

Application Number Title Priority Date Filing Date
GR74816A GR82020B (enExample) 1983-05-25 1984-05-24

Country Status (19)

Country Link
US (1) US4464380A (enExample)
EP (1) EP0127412B1 (enExample)
JP (1) JPS604183A (enExample)
KR (1) KR860001869B1 (enExample)
AT (1) ATE57531T1 (enExample)
AU (1) AU543916B2 (enExample)
CA (1) CA1266270A (enExample)
DE (1) DE3483402D1 (enExample)
DK (1) DK163924C (enExample)
ES (2) ES8600764A1 (enExample)
FI (1) FI78699C (enExample)
GR (1) GR82020B (enExample)
HU (1) HU190548B (enExample)
IE (1) IE57520B1 (enExample)
IL (1) IL71904A (enExample)
PH (1) PH21151A (enExample)
PL (3) PL143070B1 (enExample)
PT (1) PT78625A (enExample)
YU (2) YU43931B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
ES2187603T3 (es) * 1995-10-18 2003-06-16 Hoffmann La Roche Hidroximetilacion de tocoferoles.
BR9916371A (pt) 1998-12-19 2001-09-18 Janssen Pharmaceutica Nv Composto de espiro anti-histamìnico
WO2007091948A2 (en) * 2006-02-07 2007-08-16 Astrazeneca Ab Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4490381A (en) * 1979-11-13 1984-12-25 Imperial Chemical Industries Plc 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives

Also Published As

Publication number Publication date
KR860001869B1 (ko) 1986-10-24
US4464380A (en) 1984-08-07
YU212286A (en) 1987-10-31
EP0127412A3 (en) 1987-09-02
AU543916B2 (en) 1985-05-09
ES532736A0 (es) 1985-10-16
YU43958B (en) 1989-12-31
DK250084D0 (da) 1984-05-22
HUT34194A (en) 1985-02-28
FI842079A0 (fi) 1984-05-24
YU89784A (en) 1987-04-30
ES8607304A1 (es) 1986-06-01
IL71904A (en) 1988-01-31
ATE57531T1 (de) 1990-11-15
JPS604183A (ja) 1985-01-10
JPH0573754B2 (enExample) 1993-10-15
ES8600764A1 (es) 1985-10-16
PL247804A1 (en) 1985-08-13
EP0127412B1 (en) 1990-10-17
AU2856384A (en) 1984-11-29
HU190548B (en) 1986-09-29
KR840009101A (ko) 1984-12-24
DK163924C (da) 1992-09-14
FI78699C (fi) 1989-09-11
IE841294L (en) 1984-11-25
DK163924B (da) 1992-04-21
YU43931B (en) 1989-12-31
PL143290B1 (en) 1988-02-29
EP0127412A2 (en) 1984-12-05
IE57520B1 (en) 1993-05-19
PL252850A1 (en) 1985-11-19
IL71904A0 (en) 1984-09-30
DK250084A (da) 1984-11-26
CA1266270A (en) 1990-02-27
DE3483402D1 (de) 1990-11-22
FI842079A7 (fi) 1984-11-26
PT78625A (en) 1984-06-01
FI78699B (fi) 1989-05-31
ES540858A0 (es) 1986-06-01
PH21151A (en) 1987-07-30
PL143070B1 (en) 1988-01-30

Similar Documents

Publication Publication Date Title
ES8801790A1 (es) Un procedimiento para la preparacion de derivados de indol
AU2769689A (en) Pharmaceutical preparation for the treatment of hypertension using a potassium channel activator and a B-blocker antihypertensive agent
AU543916B2 (en) Spiro(imidazolidine-indolines) and spiro (imidazolidine- azaindolines)
HU907025D0 (en) Process for producing substituted n-(imidazolyl-alkyl)-alanine derivatives and pharmaceutical preparatives containing these compounds as active substance
AU7767287A (en) New imidazolylguanidine derivatives, processes for their preparation and medicaments containing these compounds
IE851155L (en) Benzo-(pyrano and thiopyrano)-pyridines
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
IE800109L (en) Spiro-quinolylhydantoins
IL76345A (en) Proline derivatives and antihypertensive and anti-glaucoma pharmaceutical preparations containing the same
IE800672L (en) Spiro-quinolone hydantoins
MY101896A (en) New tetracyclic indole derivatives
AU2773184A (en) Spiro(imidazolidine-4,3:-indoline) derivatives
HUT44769A (en) Process for producing spiro/benzofuran-2(3h),1'-cycloheptane/ derivatives and pharmaceutical preparations comprising these compounds
FI832959A0 (fi) Spiro/2h-1,4-benzodiazepin-3(5h)4'-piperidin och 3'-pyrrolidin/foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
MX9605604A (es) Nuevos compuestos agonistas.